Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Brimonidine for Optic Nerve Head Perfusion in POAG
NCT06730516Phase 1Completed
- Sponsor
- Zagazig University
- Start
- Jun 2024
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in primary open-angle glaucoma (POAG) comparing Latanoprost with Brimonidine (2 arms). Primary endpoint: Optic Nerve Perfusion using OCT angiography at 3 months. Started Jun 2024; status: completed.
02
Drugs
latanoprostbrimonidine
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT06730516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06730516.